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SUMMARY 
Introduction and methods: A bone marrow examina-
tion had been requested by the referring clinician in 
over half of the 250 patients referred to the haematolo-
gy clinic at Konfo Anokye Teaching Hospital (KATH) 
between 1988 and 1998 for investigations for various 
haematological disorders. Although a full blood count 
and a peripheral blood film can go a long way to re-
solve some of these diagnostic challenges faced by 
doctors in the districts, this information was generally 
not provided in the referral letter. After careful selec-
tion, 80 patients actually underwent a bone marrow 
examination. The result of the full blood count and 
peripheral film were available before bone marrow 
sampling was done.  
Results: Lymphoproliferative disorders were the most 
common diseases that caused infiltration of the bone 
marrow.  27.5% of lymphomas were diagnosed on 
morphological examination of the bone marrow as high 
grade B cell NHL, 13.75% had tropical splenic lym-
phoma, 10% had chronic lymphocytic leukaemia 
(CLL) and 5% had disseminated high grade T cell 
lymphoma and 2.5% had Adult T cell Leukaemia 
Lymphoma (ATLL). Other disorders diagnosed after 
bone marrow examination include myelodysplastic 
syndrome (MDS), aplastic anaemia, megaloblastic 
anaemia and myelofibrosis. Only 8.75% of these pa-
tients had a normal bone marrow.  
Conclusions: This study has demonstrated the com-
plexity of using bone marrow examination in clinical 
diagnosis and emphasizes the need for referring clini-
cians to consider involving specialist input in difficult 
haematological cases before requesting bone marrow 
examination for their patients.  
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INTRODUCTION 
A great variety of cells, haemopoetic and non-
haemopoetic are present within normal bone marrow.  
Bone marrow aspirates and bone marrow biopsy spec-
imens have important and complimentary roles in clin-
ical diagnosis.  Bone marrow aspiration provides a 
small sample, which is diluted with blood, and pro-
vides important information about the appearance of 
cells.  Trephine biopsy allows the visualization of the 
bone marrow structure and the relationship of cells to 
one another.1 Marrow aspiration and biopsy have no 
absolute contraindications but there may be some rela-
tive contraindications related to the general conditions 
of the patient.2 Complications associated with bone 
marrow aspiration and trephine biopsy are well recog-
nized but rare.3 Haemorrhage remains the single most 
common serious adverse event. 
 
Examination of the bone marrow aspirate or biopsy 
specimen is a valuable diagnostic procedure in patients 
with known or suspected haematological disorders and 
also for diagnosis of metastatic spread of non-
haematological malignancies and metabolic disorders.  
Morphology and immunophenotyping of the cells 
combined with histological examination of bone mar-
row trephine biopsy specimen are used for staging 
lymphomas and for indicating prognosis and monitor-
ing treatment.4   
 
It is usual practice in Ghana for patients to be referred 
to a tertiary centre with a request to perform a bone 
marrow examination. However there are very few 
trained physicians available who can perform these 
procedures to the required standard and there is poten-
tial for them to be over-burdened by these requests 
from District and Regional hospitals. The purpose of 
this study is to describe referral patterns for patients 
attending a teaching hospital haematology clinic. The 
process of bone marrow examination and how this ex-
amination affected the final diagnosis is also described 
in order to demonstrate the need for referring clinicians 
to consider involving specialist input to difficult hae-
matological cases before requesting bone marrow ex-












The haematology clinic was set up in Komfo Anokye 
Teaching Hospital (KATH) in 1986 and became a plat-
form for research into patients with splenomegaly.  
During the period from 1988-1998, 250 Ghanaian pa-
tients with suspected haematological problems were 
referred to the haematology clinic for evaluation and 
treatment.  The reasons for their referral included in-
vestigation for anaemia, jaundice and lymphadenopa-
thy. In addition to the Hematologist consultation, more 
than 50% of the referrals requested for bone marrow 
biopsy. 
 
The Committee on Human Research, Publications and 
Ethics of Kwame Nkrumah University of Science and 
Technology (KNUST) and KATH gave approval for 
the study of splenic lymphoma with villous lympho-
cytes (Tropical splenic lymphoma) and consent was 
obtained before recruitment into the study.  Part of the 
study was based in St Georges Hospital Medical 
School, London UK. 
 
All patients, had a clinical history and detailed clinical 
examination documented.  At the initial consultation, 
clinical evidence of the following was specifically 
looked for: weight loss, fever, tiredness related to 
anaemia, lymphadenopathy and jaundice. A full blood 
count (done using a Coulter autoanalyser) and periph-
eral film were performed. Further tests such as lymph 
node biopsy liver function test, routine urine analysis, 
and reticulocyte counts for patients who presented with 
jaundice were done if clinically indicated. 
 
Bone marrow aspirate and trephine were done using 
standard procedures2 on all patients with suspected 
lymphomas (patients with splenomegaly, lymphade-
nopathy, a bleeding disorder or nonspecific symptoms 
such as malaise, weight loss or sweats) or pancytopenia 
and on any patient whose peripheral blood film did not 
reveal a diagnosis. The total number of patients in the-
se categories was 80. When appropriate (patients with 
high WBC count or those with pancytopenia or un-
known diagnosis) peripheral blood and bone marrow 
aspirate and trephine biopsy for patients were sent to St 
Georges Hospital Medical School, London, UK for 
immunophenotyping using the alkaline phosphatase 




Eighty patients being investigated for anaemia, jaun-
dice and massive splenomegaly had bone marrow aspi-
rate and trephine biopsy done.   
There were 49 females and 31 males. Their ages 
ranged from 10 – 75 years with a mean age of 32 years. 
The mean haemoglobin was 7.8g/dl (range 2.4 – 15.6).  
Anaemia of unknown cause and splenomegaly of un-
known cause were the commonest reasons for referral, 
each accounting for 22.5% of cases. In 14 patients 
(17.5%), the diagnosis was unknown. Acute leukaemia 
and pancytopenia of unknown cause accounted for 
1.25% and 3.75% of referrals respectively. About one 
third of referrals were on account of suspicions of 
Lymphoma and Chronic Lymphocytic leukaemia. Ta-
ble 1 shows the diagnoses made by the referring doc-
tors. 
 
Table 1 Diagnostic groups based on physicians’ refer-
ral 
Diagnosis   N (%) 
Anaemia of unknown cause 18 (22.5) 
Splenomegaly of unknown cause 18 (22.5) 
Possible lymphoma  13 (16.25) 
Chronic lymphocytic leukaemia 13 (16.25) 
Pancytopenia of unknown cause 3 (3.75) 
Acute leukaemia 1 (1.25) 
Diagnosis unknown 14 (17.5) 
Total  80 (100) 
 
Sixty (60) of the 80 patients (75%) had hepatomegaly 
and 72  (90%)) had moderate to massive splenomegaly. 
18% had conjunctival pallor and 6% were jaundiced. 
Forty eight (48) patients (60%) had lymphadenopathy, 
which was mainly limited to the cervical nodes. Twen-
ty-nine patients (36.25%) had leucocyte count greater 
than 10 × 109/L. Forty percent of patients had absolute 
lymphocyte count greater than 3.5 × 109/L while 15% 
had evidence of haemolysis. Laboratory results are 
presented in Table 2.  
 
Table 2 Laboratory results 
Investigation / Result N (%)  
Patients with leucocytosis >10 × 109/L 29 (36.3) 
Patients with absolute lymphocyte count 
> 3.5 × 109/L 
32 (40) 
Patients with evidence of haemolysis 
(jaundice, raised reticulocyte count, un-
conjugated hyperbilirubinaemia, in-
creased urobilinogen in urine) 
12 (15) 
 
The diagnoses of the 80 patients who had bone marrow 
sampling done (Table 3) showed that lymphomas were 













Table 3: Final diagnosis after bone marrow sampling 
Diagnosis  N % 
High grade B cell NHL  22 27.50 
Tropical splenic lymphoma 11 13.75 
Chronic lymphocytic leukaemia 8 10.00 
Disseminated high grade T cell lymphoma 4 5.00 
Multiple myeloma 3 3.75 
Adult T cell leukaemia/lymphoma 2  2.50 
Hodgkin lymphoma 1  1.25 
Acute leukaemia 2 2.50 
Metastatic prostate carcinoma 1  1.25 
Myelodysplastic syndrome 1  1.25 
Aplastic anaemia 5 6.25 
Megaloblastic anaemia 2  2.50 
Myelofibrosis 3  3.75 
Erythroid hyperplasia 8 10.00 
Normal marrow 7  8.75 
Total 80 100 
 
Table 4 Comparison of “referral diagnosis” and “final diagnosis” after bone marrow sampling 
Referral diagnosis Number of 
patients 
Final diagnosis Number of 
patients 




Metastatic prostate carcinoma 
Megaloblastic anaemia 
Acute leukaemia 









Splenomegaly 18 TSL 





Possible Lymphoma 13 High grade T cell lymphoma 





CLL 13 CLL 
HD 

























Total 80  80 
 
Legend 
AA- aplastic anaemia, MDS-Myelodysplastic syndrome, MF-Myelofibrosis, TSL-tropical splenic lymphoma, CLL-
chronic lymphocytic leukaemia, HD-Hodgkin’s Lymphoma, NHL-non Hodgkin’s Lymphoma, MM-multiple mye-









Table 4 represents a comparison between the referring 
Physicians diagnosis and that made after examination 
of the bone marrow. Of the 18 patients referred as 
‘anaemia of unknown cause’, the exact causes of the 
anaemia were determined to be aplastic anaemia (4), 
myelodysplastic syndrome (1) and metastatic prostate 
carcinoma (1). Others in this category had megalo-
blastic anaemia (2), acute leukaemia (1) and high grade 
B cell NHL (3). Six of the patients referred under this 
category had a normal bone marrow examination. 
Eleven of the 18 patients referred with a diagnosis of 
‘splenomegaly’ were found to have tropical splenic 
lymphoma while there were 4 and 3 patients with high 
grade B cell NHL and myelofibrosis respectively. 
Fourteen patients referred with unknown diagnosis 
were determined to have erythroid hyperplasia (8), 
multiple myeloma (3), high grade B cell lymphoma (2) 
and ATLL (1).   
 
In all, twenty-two patients (27.5%) had grade B cell 
lymphoma, 13.75% has Tropical splenic lymphoma 
whilst 5% had disseminated high-grade T cell lym-
phoma and 2.5% had Adult T cell leukae-
mia/lymphoma (ATLL). One patient had nodular scle-
rosing-lymphocyte depleted Hodgkin’s disease. Chron-
ic lymphocytic leukaemia (CLL) accounted for 10% of 
the lymphoid malignancies and 1 patient suffered from 
Myelodysplastic syndrome. Two patients (2.5%) had 
acute leukaemia, one was acute myelomonocytic leu-
kaemia and the other was acute myeloid leukaemia. 
Uncommon diagnoses on bone marrow examination 
included metastatic prostate carcinoma, aplastic anae-
mia, megaloblastic anaemia and myelofibrosis. Eight 
patients (10%) had erythroid hyperplasia while 7 
(8.75%) had normal bone marrow.   
 
DISCUSSION 
This study demonstrated that in this group of haema-
tology clinic patients selected for bone marrow exami-
nation using specific criteria, bone marrow examina-
tion was very helpful in determining the diagnosis. The 
bone marrow was normal in 8.75% of these carefully 
selected patients. Bone marrow examination was able 
to elucidate the underlying cause of several syndromes 
that are common reasons for referral to haematologists 
in Africa such as anaemia, pancytopenia and spleno-
megaly.  Lymphoproliferative disorders were the most 
common diagnoses and a detailed description of a se-
lection of these patients has been published previous-
ly.6 Important but unsuspected diagnoses, such as 
myelodysplastic syndrome, aplastic anaemia, megalo-
blastic anaemia, and myelofibrosis would have been 
missed without a bone marrow examination. 
 
A bone marrow biopsy specimen may be diagnostic in 
patients without lymphadenopathy or when there is no 
conclusive histological evidence from other sites.  
Bone marrow involvement is a frequent finding in 
lymphoproliferative disease and can be detected by a 
variety of techniques involving morphologic examina-
tion of bone marrow biopsies and aspirate smears, flow 
cytometric analysis of aspirate samples and immuno-
chemistry of tissue samples (e.g. lymph nodes, bone 
marrow) for B and T cell markers and molecular genet-
ic analysis using polymerase chain reaction (PCR).7 
Discordance between the type of lymphoma found on 
lymph node biopsy and that found in the marrow has 
been reported.8 Some of these investigations are not 
available in Ghana but through a partnership with an 
external laboratory it is possible to receive results on 
samples from patients in Kumasi sent to an internation-
al centre of excellence within a couple of weeks. This 
is an adequate time frame to influence the clinical care 
of the patients.9  
 
Bone marrow and trephine biopsy should only be car-
ried out when clinically indicated.1 The results of the 
full blood count and blood film should be available 
before a bone marrow examination is undertaken since 
these more simple tests may be sufficient to provide a 
diagnosis. An abnormal blood count or film does not 
necessarily indicate a primary haematological disorder 
because it may reflect a non-haematological condition.  
A primary blood disease should be considered when a 
patient has splenomegaly, lymphadenopathy a bleeding 
disorder or nonspecific symptoms such as malaise, 
weight loss or sweats, which are symptoms characteris-
tic of lymphomas or leukaemias. An accurate diagnosis 
of the sub-type of lymphoma is critical since it guides 
the treatment and prognosis.   
 
The key lessons from this study are that bone marrow 
aspirate and trephine are not a routine procedure and 
should only be performed when indicated.  Patients 
referred to a specialist should have recent full blood 
count and film comments available.  Interpretation of 
bone marrow findings is complicated and needs to take 
into account the patient’s clinical history, examination 
and laboratory results. A high quality bone marrow 
sample is needed and this needs to be processed by a 
laboratory experienced in dealing with bone marrow 
samples. For all these reasons the decision to recom-
mend bone marrow sampling should be taken by a phy-
sician with haematology expertise and bone marrow 
processing should be undertaken in a specialist haema-
tology unit. An onward referral system needs to be in 
place for complicated cases, which cannot be resolved 
locally, and this may include facilities for sending 
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